Chemed Corp. buy Royal Bank of Canada
Start price
28.04.25
/
50%
€492.00
Target price
28.04.26
€593.59
Performance (%)
-32.11%
Price
27.02.26
€332.00
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Chemed Corp. is performing very badly with a performance of -32.11%. This prediction currently runs until 28.04.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Chemed Corp. | -17.413% | -17.413% |
| iShares Core DAX® | -0,38 % | 1,09 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % |
| iShares S&P 500 | -0,71 % | 0,44 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Chemed Corp. diskutieren
Chemed Co. (NYSE: CHE) had its price target raised by analysts at Royal Bank of Canada from $667.00 to $674.00. They now have an "outperform" rating on the stock.
Ratings data for CHE provided by MarketBeat